The GDF-15 serum levels (pg/mL) were significantly higher in cancer patients (median 6.84, IQR 6.61; 7.32) with respect to controls (median 6.31, IQR 6.09; 6.73) (p = 0.00016) (Figure 1A). This evidence concerns the gene GDF15 and cancer.